Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04188145
Title A Randomized Phase III Study Comparing Maintenance Treatment With Fluoropyrimidine + Bevacizumab Versus Fluoropyrimidine After Induction Chemotherapy for a Metastatic Colorectal Cancer (BEVAMAINT)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Centre Hospitalier Universitaire Dijon
Indications

colorectal adenocarcinoma

Therapies

Capecitabine

Fluorouracil + Leucovorin

Bevacizumab

Bevacizumab + Fluorouracil + Leucovorin

Bevacizumab + Capecitabine

Age Groups: adult | senior
Covered Countries


No variant requirements are available.